hydralazine hydrochloride

Generic: hydralazine hydrochloride

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name hydralazine hydrochloride
Generic Name hydralazine hydrochloride
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydralazine hydrochloride 100 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 43353-124
Product ID 43353-124_66435209-390b-4344-9b5b-47c9c2d92e2f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA089098
Listing Expiration 2026-12-31
Marketing Start 1990-09-30

Pharmacologic Class

Classes
arteriolar vasodilation [pe] arteriolar vasodilator [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43353124
Hyphenated Format 43353-124

Supplemental Identifiers

RxCUI
905222
UNII
FD171B778Y

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hydralazine hydrochloride (source: ndc)
Generic Name hydralazine hydrochloride (source: ndc)
Application Number ANDA089098 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 4200 TABLET in 1 BOTTLE (43353-124-05)
source: ndc

Packages (1)

Ingredients (1)

hydralazine hydrochloride (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "66435209-390b-4344-9b5b-47c9c2d92e2f", "openfda": {"unii": ["FD171B778Y"], "rxcui": ["905222"], "spl_set_id": ["d9892176-d4a6-4edb-92b9-5f56243f3d22"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "4200 TABLET in 1 BOTTLE (43353-124-05)", "package_ndc": "43353-124-05", "marketing_start_date": "20151202"}], "brand_name": "Hydralazine Hydrochloride", "product_id": "43353-124_66435209-390b-4344-9b5b-47c9c2d92e2f", "dosage_form": "TABLET", "pharm_class": ["Arteriolar Vasodilation [PE]", "Arteriolar Vasodilator [EPC]"], "product_ndc": "43353-124", "generic_name": "Hydralazine Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydralazine Hydrochloride", "active_ingredients": [{"name": "HYDRALAZINE HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA089098", "marketing_category": "ANDA", "marketing_start_date": "19900930", "listing_expiration_date": "20261231"}